Lucid Diagnostics (LUCD) Cost of Revenue (2021 - 2025)
Lucid Diagnostics (LUCD) has disclosed Cost of Revenue for 5 consecutive years, with -$3.3 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Cost of Revenue fell 180.52% year-over-year to -$3.3 million, compared with a TTM value of -$550000.0 through Sep 2025, down 103.26%, and an annual FY2024 reading of $7.1 million, down 56.72% over the prior year.
- Cost of Revenue was -$3.3 million for Q3 2025 at Lucid Diagnostics, down from $6.5 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $6.5 million in Q2 2025 and bottomed at -$5.4 million in Q4 2024.
- Average Cost of Revenue over 5 years is $1.9 million, with a median of $1.6 million recorded in 2022.
- The sharpest move saw Cost of Revenue surged 381.57% in 2022, then crashed 221.6% in 2024.
- Year by year, Cost of Revenue stood at -$2.0 million in 2021, then skyrocketed by 179.24% to $1.6 million in 2022, then surged by 172.44% to $4.4 million in 2023, then plummeted by 221.6% to -$5.4 million in 2024, then soared by 39.07% to -$3.3 million in 2025.
- Business Quant data shows Cost of Revenue for LUCD at -$3.3 million in Q3 2025, $6.5 million in Q2 2025, and $1.6 million in Q1 2025.